SJM
12
-4
GS
72
-3
AVB
30
-2
HRL
30
-5
MMM
54
-3
MUR
33
-5
CNP
55
-2
DGX
36
-4
HPQ
37
2
OI
50
-6
EQR
39
-3
MDLZ
22
-2
PFE
34
-7
PHM
55
-3
NOV
47
-6
ABBV
50
-9
ABT
42
-3
DLTR
64
-2
CAH
56
-2
AEE
53
-5
SJM
12
-4
GS
72
-3
AVB
30
-2
HRL
30
-5
MMM
54
-3
MUR
33
-5
CNP
55
-2
DGX
36
-4
HPQ
37
2
OI
50
-6
EQR
39
-3
MDLZ
22
-2
PFE
34
-7
PHM
55
-3
NOV
47
-6
ABBV
50
-9
ABT
42
-3
DLTR
64
-2
CAH
56
-2
AEE
53
-5
Financhill
Back

Blackbaud, Inc. Vs. Halozyme Therapeutics, Inc. Industry Stock Comparison

Buy
62

BLKB
Blackbaud, Inc.

Last Price:
$63.01
Seasonality Move:
-0.68%
Buy
71

HALO
Halozyme Therapeutics, Inc.

Last Price:
$65.55
Seasonality Move:
8.05%
Buy
62
Blackbaud, Inc. (BLKB) is a Buy

Is Blackbaud, Inc. a Buy, Sell or Hold?

  • The current Blackbaud, Inc. [BLKB] share price is $62.87. The Score for BLKB is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • BLKB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Halozyme Therapeutics, Inc. (HALO) is a Buy

Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Halozyme Therapeutics, Inc. [HALO] share price is $64.47. The Score for HALO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BLKB Stock Price Chart

What is Blackbaud, Inc.'s stock price today?

  • The Blackbaud, Inc. share price today is $62.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLKB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics, Inc.'s stock price today?

  • The Halozyme Therapeutics, Inc. share price today is $64.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

BLKB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.6 Buy
Relative Strength Index (14 RSI): 57.12 Buy
Chaikin Money Flow: 310805 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.01 - 62.25) Buy
Bollinger Bands (100): (60.03 - 66.91) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 43.89 Sell
Chaikin Money Flow: 1270476 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 71.48) Sell
Bollinger Bands (100): (63.53 - 73.73) Sell

BLKB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.29 Buy
20-day SMA: 59.65 Buy
50-day SMA: 61.36 Buy
200-day SMA: 63.33 Sell
8-day EMA: 61.99 Buy
20-day EMA: 60.98 Buy
50-day EMA: 61.44 Buy
200-day EMA: 65 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.85 Buy
20-day SMA: 66.78 Sell
50-day SMA: 66.93 Sell
200-day SMA: 63.29 Buy
8-day EMA: 63.68 Buy
20-day EMA: 65.48 Sell
50-day EMA: 67.07 Sell
200-day EMA: 63.61 Buy

Blackbaud, Inc. Earnings Growth & BLKB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.52 per share.

Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.15 per share, and an increase next year of $1.86 per share.

Blackbaud, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):